![]() |
產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS10816 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-phospho-PAK1(Thr212) |
克隆性 | |
靶點(diǎn) | 詳見說(shuō)明書 |
適應(yīng)物種 | 詳見說(shuō)明書 |
形態(tài) | 詳見說(shuō)明書 |
宿主 | 詳見說(shuō)明書 |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見說(shuō)明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated Synthesised phosphopeptide derived from human PAK1 around the phosphorylation site of Thr212 |
產(chǎn)品訂購(gòu)信息:
英文名稱 Anti-phospho-PAK1(Thr212)
中文名稱 磷酸化p21激活激酶1抗體說(shuō)明書
別 名 PAK1(Phospho-Thr212); PAK1(phospho T212); Alpha PAK; Alpha-PAK; MGC130000; MGC130001; p21 activated kinase 1; p21 protein (Cdc42/Rac) activated kinase 1; p21-activated kinase 1; p21/Cdc42/Rac1 activated kinase 1 (yeast Ste20 related); p21/Cdc42/Rac1 activated kinase 1; p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast); p65 PAK; p65-PAK; PAK alpha; PAK-1; Pak1; PAK1_HUMAN; Paka; PAKalpha; Protein kinase MUK2; Rac/p21-activated kinase; Serine/threonine-protein kinase PAK 1; STE20 homolog (yeast); STE20 homolog yeast.
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Rabbit
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 60kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human PAK1 around the phosphorylation site of Thr212
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷酸化p21激活激酶1抗體說(shuō)明書 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell.
Function : The activated kinase acts on a variety of targets. Likely to be the GTPase effector that links the Rho-related GTPases to the JNK MAP kinase pathway. Activated by CDC42 and RAC1. Involved in dissolution of stress fibers and reorganization of focal complexes. Involved in regulation of microtubule biogenesis through phosphorylation of TBCB. DVL1 and PAK1 form a ternary complex with MUSK which is important for MUSK-dependent regulation of AChR clustering during the formation of the neuromuscular junction (NMJ). Activity is inhibited in cells undergoing apoptosis, potentially due to binding of CDC2L1 and CDC2L2. Phosphorylates MYL9/MLC2. Phosphorylates RAF1 at 'Ser-338' and 'Ser-339' resulting in: activation of RAF1, stimulation of RAF1 translocation to mitochondria, phosphorylation of BAD by RAF1, and RAF1 binding to BCL2.
Subunit : Homodimer in its autoinhibited state. Active as monomer. Interacts tightly with GTP-bound but not GDP-bound CDC42/P21 and RAC1. Binds to the caspase-cleaved p110 isoform of CDC2L1 and CDC2L2, p110C, but not the full-length proteins. Component of cytoplasmic complexes, which also contain PXN, ARHGEF6 and GIT1. Interacts with ARHGEF7. Also interacts with CRIPAK. Interacts with NISCH. Interacts with DVL1; mediates the formation of a DVL1, MUSK and PAK1 ternary complex involved in AChR clustering. Probably found in a ternary complex composed of DSCAM, PAK1 and RAC1. Interacts with DSCAM (via cytoplasmic domain); the interaction is direct and enhanced in presence of RAC1. Interacts with SCRIB. Interacts with PDPK1. Interacts (via kinase domain) with RAF1. Interaction with NCK1 and NCK2.
Subcellular Location : Cytoplasm. Cell junction, focal adhesion. Note=Recruited to focal adhesions upon activation.
Similarity : Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily.
Contains 1 CRIB domain.
Contains 1 protein kinase domain.
Database links : UniProtKB/Swiss-Prot: Q13153.2
PAK1-3蛋白具有廣泛的生物學(xué)功能,也是一個(gè)保守的絲氨酸/蘇氨酸蛋白激酶,參與許多重要的細(xì)胞活動(dòng)。包括細(xì)胞骨架的動(dòng)力學(xué)調(diào)節(jié),細(xì)胞移動(dòng),生存和凋亡,細(xì)胞周期,基因轉(zhuǎn)錄調(diào)節(jié),細(xì)胞生長(zhǎng)信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)化等。
ABCA1(human) 人腺苷三磷酸結(jié)合盒轉(zhuǎn)運(yùn)蛋白A1Multi-class antibodies規(guī)格: 48T
Anti-CLEC2/CLEC1B C型凝集素結(jié)構(gòu)域家族1成員B抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh NPY1R 神經(jīng)肽Y1受體抗體 規(guī)格 0.1ml
SP Kit(Rabbit) SP免疫組化檢測(cè)試劑盒(兔) 3ml
Tal1 英文名稱: T細(xì)胞急性淋巴細(xì)胞性1蛋白/蛋白5抗體 0.1ml
C7ORF29 英文名稱: 7號(hào)染色體開放閱讀框29抗體 0.2ml
Anti-CLEC2/CLEC1B C型凝集素結(jié)構(gòu)域家族1成員B抗體Multi-class antibodies規(guī)格: 0.2ml
Anti-IL-17E/IL-25/FITC 熒光素標(biāo)記白介素-17E抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-RAR- Alpha /FITC 熒光素標(biāo)記維受體-α 抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh APAF1(NT) 凋亡蛋白活性因子-1抗體(N端) 規(guī)格 0.1ml
Rabbit anti-mouse Kappa light chain/Alexa Fluor 350 Alexa Fluor 350標(biāo)記的兔抗小鼠k鏈 0.1ml
GABA Transporter 3 英文名稱: γ基運(yùn)載蛋白3抗體 0.2ml
Rhesus antibody Rh Rabbit Anti-human IgM/Cy5 Cy5標(biāo)記的兔抗人IgM 規(guī)格 0.1ml
Anti-RAR- Alpha /FITC 熒光素標(biāo)記維受體-α 抗體IgGMulti-class antibodies規(guī)格: 0.2ml
NADPH peptide 還原型輔酶Ⅱ抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-AQP5 水通道蛋白-5抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh phospho-ATG4D(Ser15) 磷酸化自噬相關(guān)蛋白4D抗體 規(guī)格 0.1ml
兔抗山羊 IgG(H+L)/HRP 0.1ml 美國(guó)Jackson公司分裝
SKA1 英文名稱: 紡錘體和著絲粒相關(guān)蛋白1抗體 0.1ml
MREG 英文名稱: MREG蛋白抗體 0.2ml
Anti-AQP5 水通道蛋白-5抗體Multi-class antibodies規(guī)格: 0.1ml
脒多粘菌素B瓊脂基礎(chǔ)250g用于炭疽桿菌的培養(yǎng)及初步鑒定
DEV nutrient gelatin DEV營(yíng)養(yǎng)明膠 1.10691.0500 MERCK默克 incubation media DEV nutrient gelatin DEV營(yíng)養(yǎng)明膠 1.10691.0500 MERCK默克
水解酪蛋白胨(MH)肉湯 100g 適用于稀釋法進(jìn)行藥敏試驗(yàn)。
Wistar大鼠脂肪間質(zhì)干細(xì)胞成脂誘導(dǎo)分化培養(yǎng)基Wistarofratadiposederivedmesenchymalstemcellsintotheculturemediuminduceddifferentiationoffat
含0.6%酵母膏的胰酪胨大豆瓊脂(TSA-YE) 250g 用于單增李氏菌的分純,培養(yǎng),可用于做7%羊血瓊脂
聯(lián)合固氮菌培養(yǎng)基250g用于固氮菌的分離培養(yǎng)
麥芽浸出液瓊脂 分離計(jì)數(shù)酵母和霉菌 500g incubation media 麥芽浸出液瓊脂 分離計(jì)數(shù)酵母和霉菌 500g
發(fā)根土壤桿菌(發(fā)根植物單胞菌) 支/瓶
牛津瓊脂(OXA)平板(9cm)用于單增李氏菌的選擇性分離
WL營(yíng)養(yǎng)瓊脂 250g 用于啤酒和發(fā)酵產(chǎn)品中酵母菌和細(xì)菌的計(jì)數(shù)
磷酸化p21激活激酶1抗體說(shuō)明書 尿素瓊脂培養(yǎng)基基礎(chǔ) 規(guī)格: 250g 用途: 用于鑒別腸道素酶試驗(yàn)
緩沖動(dòng)力-鹽培養(yǎng)基 規(guī)格: 250g 用途: 供產(chǎn)氣莢膜梭菌動(dòng)力和鹽還原測(cè)定用
動(dòng)力—鹽培養(yǎng)基(A法) 規(guī)格: 250g 用途: 供鑒別測(cè)定細(xì)菌液化明膠用
明膠培養(yǎng)基(營(yíng)養(yǎng)明膠) 規(guī)格: 100g 用途: 供測(cè)定細(xì)菌液化明膠使用
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn):
1. 磷酸化p21激活激酶1抗體說(shuō)明書 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件;
3.用NHSB量過(guò)量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活;
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等;
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性;
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合;
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用;
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
抗體的鑒定:
1)磷酸化p21激活激酶1抗體說(shuō)明書 抗體的效價(jià)鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。
2)抗體的特異性鑒定:抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力。抗體的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3)抗體親和力:是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol??贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。